{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:06:01Z","timestamp":1762808761117},"reference-count":38,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7290","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T10:07:33Z","timestamp":1550743653000},"source":"Crossref","is-referenced-by-count":10,"title":["Association of toll\u2011like receptor 9 expression with prognosis of systemic lupus erythematosus"],"prefix":"10.3892","author":[{"given":"Yi","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongshuang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosong","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"key20200713120550_b1-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.berh.2010.10.006","article-title":"Systemic lupus erythematosus","volume":"24","author":"O'Neill","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key20200713120550_b2-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/01.md.0000224709.70133.f7","article-title":"Predictors of survival in systemic lupus erythematosus","volume":"85","author":"Kasitanon","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"key20200713120550_b3-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/art.1780381016","article-title":"Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort","volume":"38","author":"Ward","year":"1995","journal-title":"Arthritis Rheum"},{"key":"key20200713120550_b4-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1136\/annrheumdis-2015-207347","article-title":"Prolonged remission in Caucasian patients with SLE: Prevalence and outcomes","volume":"74","author":"Zen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key20200713120550_b5-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/00005792-198105000-00004","article-title":"Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE)","volume":"60","author":"Lloyd","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"key20200713120550_b6-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/art.27267","article-title":"Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus","volume":"62","author":"Kao","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20200713120550_b7-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/ard.56.11.661","article-title":"The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation","volume":"56","author":"Bootsma","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"key20200713120550_b8-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2249.2009.04036.x","article-title":"Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus","volume":"159","author":"Wong","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"key20200713120550_b9-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.imbio.2008.10.004","article-title":"The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population","volume":"214","author":"Wu","year":"2009","journal-title":"Immunobiology"},{"key":"key20200713120550_b10-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12383","article-title":"Endosomal Toll-like receptors in clinically overt and silent autoimmunity","volume":"269","author":"Clancy","year":"2016","journal-title":"Immunol Rev"},{"key":"key20200713120550_b11-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J Clin Invest"},{"key":"key20200713120550_b12-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1002\/art.22197","article-title":"Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: Implications for the induction and maintenance of the autoimmune process","volume":"54","author":"Papadimitraki","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20200713120550_b13-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"key20200713120550_b14-etm-0-0-7290","first-page":"1265","article-title":"Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality","volume":"22","author":"Abu-Shakra","year":"1995","journal-title":"J Rheumatol"},{"key":"key20200713120550_b15-etm-0-0-7290","first-page":"1259","article-title":"Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death","volume":"22","author":"Abu-Shakra","year":"1995","journal-title":"J Rheumatol"},{"key":"key20200713120550_b16-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/rheumatology\/38.8.724","article-title":"High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosus","volume":"38","author":"Formiga","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713120550_b17-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key20200713120550_b18-etm-0-0-7290","first-page":"856","article-title":"Disease activity patterns in a monocentric cohort of SLE patients: A seven-year follow-up study","volume":"30","author":"Zen","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"key20200713120550_b19-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"key20200713120550_b20-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1136\/jcp.34.9.1032","article-title":"Double-stranded DNA antibodies: A comparison of four methods of detection","volume":"34","author":"Somerfield","year":"1981","journal-title":"J Clin Pathol"},{"key":"key20200713120550_b21-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/ard.2003.016303","article-title":"Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: The role of analytical diversity","volume":"63","author":"Haugbro","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"key20200713120550_b22-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/art.22356","article-title":"Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus","volume":"55","author":"Ng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20200713120550_b23-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0002-9343(79)90529-1","article-title":"Serologically active clinically quiescent systemic lupus erythematosus: A discordance between clinical and serologic features","volume":"66","author":"Gladman","year":"1979","journal-title":"Am J Med"},{"key":"key20200713120550_b24-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/art.24741","article-title":"Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus","volume":"61","author":"Nikpour","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key20200713120550_b25-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1002\/art.22198","article-title":"The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double-blind, placebo-controlled trial","volume":"54","author":"Tseng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20200713120550_b26-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713120550_b27-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1248\/bpb.28.886","article-title":"Tissue-specific mRNA expression profiles of human toll-like receptors and related genes","volume":"28","author":"Nishimura","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"key20200713120550_b28-etm-0-0-7290","first-page":"372","article-title":"Cloning and characterization of a sub-family of human toll-like receptors: HTLR7, hTLR8 and hTLR9","volume":"11","author":"Chuang","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"key20200713120550_b29-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"710720","DOI":"10.1155\/2015\/710720","article-title":"Correlation between TLR9 expression and cytokine secretion in the clinical diagnosis of systemic lupus erythematosus","volume":"2015","author":"Rao","year":"2015","journal-title":"Mediators Inflamm"},{"key":"key20200713120550_b30-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2249.2008.03646.x","article-title":"Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"152","author":"Komatsuda","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"key20200713120550_b31-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/08923973.2016.1263859","article-title":"Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-\u03b1 production in SLE patients","volume":"39","author":"Mortezagholi","year":"2017","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"key20200713120550_b32-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s10495-010-0478-8","article-title":"Inefficient clearance of dying cells in patients with SLE: Anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players","volume":"15","author":"Kruse","year":"2010","journal-title":"Apoptosis"},{"key":"key20200713120550_b33-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/rheumatology\/kem327","article-title":"Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus","volume":"47","author":"Nakano","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713120550_b34-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/0961203309351033","article-title":"SLE disease patterns in a Danish population-based lupus cohort: An 8-year prospective study","volume":"19","author":"Laustrup","year":"2010","journal-title":"Lupus"},{"key":"key20200713120550_b35-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/acr.22774","article-title":"Analysis of complete remission in systemic lupus erythematosus patients over a 32-year period","volume":"68","author":"Medina-Qui\u00f1ones","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key20200713120550_b36-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4149\/neo_2011_03_251","article-title":"Association of Toll like receptor 9 expression with lymph node metastasis in human breast cancer","volume":"58","author":"Qiu","year":"2011","journal-title":"Neoplasma"},{"key":"key20200713120550_b37-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1096\/fj.03-0646fje","article-title":"Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas (lpr) mice","volume":"18","author":"Anders","year":"2004","journal-title":"FASEB J"},{"key":"key20200713120550_b38-etm-0-0-7290","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.4049\/jimmunol.173.7.4479","article-title":"CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10","volume":"173","author":"He","year":"2004","journal-title":"J Immunol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T11:33:48Z","timestamp":1594640028000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7290","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]}}}